Neural grafting as a tool for the study and reversal of neurobehavioral birth defects

Pharmacology Biochemistry and Behavior

Volumn 55, Issue 4, 1996, Pages 673-681

  Yanai, Joseph ^a   Abu Roumi, Moussa ^a   Silverman, William F ^b   Steingart, Ruth A ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

acetylcholine; behavior; heroin; hippocampus; mice; neural grafting; neurobehavioral teratology; phenobarbital; protein kinase C

Indexed keywords

DIAMORPHINE; PHENOBARBITAL; PHYSOSTIGMINE; PROTEIN KINASE C;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; BIRTH DEFECT; ENZYME ACTIVITY; MOUSE; NEUROBIOLOGY; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; SYNAPSE; TERATOGENICITY; TERATOLOGY;

ABNORMALITIES; ANIMALS; BEHAVIOR, ANIMAL; BRAIN TISSUE TRANSPLANTATION; CELL TRANSPLANTATION; FEMALE; FETAL TISSUE TRANSPLANTATION; HEROIN; HIPPOCAMPUS; HYPNOTICS AND SEDATIVES; INOSITOL PHOSPHATES; MAZE LEARNING; MICE; MICE, INBRED STRAINS; NARCOTICS; NERVOUS SYSTEM DISEASES; NEURONS; PARASYMPATHETIC NERVOUS SYSTEM; PHENOBARBITAL; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PROTEIN KINASE C;

EID: 0030478131     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(96)00252-3     Document Type: Article

References (83)

1. 1. Abu-Roumi, M.; Newman, M. E.; Yanai, J. Muscarinic receptor related inositol phosphate formation in mice prenatally-exposed to drugs. Brain Res. Bull. in press.
2. 2. Akers, R. P.; Lovin, D. M.; Colley, P.; Linden, D. J.; Routtenberg, A. Translocation of PKC activity may mediate hippocampal long-term potentiation. Science, 231:374-378; 1986.
3. 3. Arendt, T.; Allen, Y.; Sindin, J.; Schugens, M. M.; Marchbanks, R. M.; Lantos, P. L; Gray, J. A. Cholinergic-rich brain transplants reverse alcohol-induced memory deficits. Nature 332:448-450; 1989.
4. 4. Bankiewicz, S.; Plunkett, R.; Jacobowitz, D.; Kopin, I.; Oldfield, E. Fetal nondopaminergic neural implants in parkinsonian primates. J. Neurosurg. 74:97-104; 1991.
5. 5. Berridge, M. J.; Dawson, R. M. C.; Downes, C. P.; Heslop, J. P.; Irvine, R. F. Changes in the levels of inositol phosphates after agonist-dependent hydrolysis of membranephosphoinositides. Biochem. J. 212:473-482; 1983.
6. 6. Bjorklund, A.; Stenevi, U. Reformation of the severed septohippocampal cholinergic pathway in the adult rat by transplanted septal neurons. Cell Tissue Res. 185:289-302; 1977.
7. 7. Bjorklund, A.; Stenevi, U. Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants. Brain Res. 177:555-560; 1979.
8. 8. Bohn, M. C.; Cupit, L.; Marciano, F. Adrenal medulla grafts enhance recovery of striatal dopaminergic fibers. Science 237:913-915; 1987.
9. 9. Brundin, P.; Isacson, O.; Bjorklund, A. Monitoring of cell viability in suspensions of embryonic CNS tissue and its use as criterion for intracerebral graft survival. Brain Res. 331:251-259; 1985.
10. 10. Chang, H. T. Dopamine-acetylcholine interaction in the rat striaturn: A dual-labeling immunocytochemical study. Brain Res. Bull. 21:295-304; 1988.
11. 11. Cheney, D. L.; Lehmann, J.; Cosi, C.; Wood, P. L. Determination of acetylcholine dynamics. Drugs Neurotransmit. Res. 12:443-495; 1989.
12. 12. Clarke, D. J.; Gage, F. H.; Nilsson, O. G.; Bjorklund, A. Grafted septal neurons form cholinergic sytnaptic connections in the dentate gyrus of behaviorally impaired aged rats. J. Comp. Neurol. 252:483-492; 1986.
13. 13. Cooper, J. R.; Bloom, F. E.; Roth, R. H. The biochemical basis of neuropharmacology, 5th ed. New York: Oxford University Press; 1986.
14. 14. Doberczak, T. M., Kandall, S. R., Wilets, I. Neonatal opiate abstinence syndrome in term and preterm infants. J. Pediatr. 118(6):933-937; 1991.
15. 15. Dunnet, S. B.; Everitt, B. J.; Robbins, T. W. The basal forebrain-cortical cholinergic system: Interpreting the functional consequences of exotoxic lesions. Trends Neurosci. 14:494-500; 1991.
16. 16. Ebendal, T. NGF in CNS: Experimental data and clinical implications. Prog. Growth Factor Res. 1:143-159; 1989.
17. 17. Freed, W. J. Substantia nigra grafts and Parkinson's disease: From animal experiments to human therapeutic trials, Restor. Neurol. Neurosci. 3:109-134; 1991.
18. 18. Gage, F. H.; Ray, J.; Fisher, L. J. Isolation, characterization, and use of stem cells from the CNS. Annu. Rev. Neurosci. 18:159-192; 1995.
19. 19. Giannuzzi, C. E.; Seidler F. J.; Slotkin. T. A.; βAdrenoceptor control of cardiac adenylyl cyclase during development: Agonist pretreatment in the neonate uniquely causes heterologous sensitization, not desensitization. Brain Res. in press.
20. 20. Gil, D. G.,; Wolfe, B. B. Pirenzepine distinguishes between muscarinic receptor-mediated phosphoinositide breakdown and inhibition of adenylate cyclase. Therapeutics 232(3):608-616; 1985.
21. 21. Jaffard, R.; Ebel, A.; Destade, C.; Durkin, T.; Mandel, P.; Cardo, B. Effects of hippocampal electrical stimulation on longterm memory and on cholinergic mechanisms in three inbred strains of mice. Brain Res. 133:277-290; 1977.
22. 22. Jope, R. S. High affinity choline transport and acetylCoA production in brain and their roles in the regulation of acetylcholine synthesis. Brain Res. Rev. 1:314-344; 1979.
23. 3H]acetylcholine to muscarinic cholinergic receptors. J. Neurosci. 5:1577-1582; 1985.
24. 24. Kikkawa, U.; Takai, Y.; Minakuchi, R.; Inohara, S.; Nishizoka, Y. Calcium activated phospholipid dependent protein kinase from rat brain: Subcellular distribution, purification and properties. J. Biol. Chem. 257:13341-13348; 1982.
25. 25. Kikkawa, U.; Kishimoto, A.; Nishizuka, Y. The protein kinase C familiy: Heterogeneity and its impication. Annu. Rev. Biochem. 58:31-44; 1989.
26. 26. Kleinberger, N.; Yanai, J. Early phenobarbital-induced alterations in hippocampal acetylcholinesterase activity and behavior. Dev. Brain Res. 22:113-123; 1985.
27. 27. Klemm, N.; Kuhar, M. J. Post-mortem changes in high affinity choline. J. Neurochem. 32:1487-1494; 1979.
28. 28. Kondoh, T.; Blount, J. P.; Conrad, J. A.; Pundt, L. L.; Low, W. C. Functional effects of transplanted human fetal ventral mesencephalic brain tissue from spontaneous abortions into a rodent model of Parkinson's disease. Transplant. Proc. 26(6):3335; 1994.
29. 29. Linden, D. J.; Routtenberg, A. The role of protein kinase C in long term potentiation a stable model. Brain Res. Rev. 14:279-296; 1989.
30. 30. Lindvall, O. Prospects of transplantation in human neurodegenerative diseases. Trends Neurosci. 14:376-388; 1991.
31. 31. Low, W. C.; Lewis, P. R.; Bunch, S. T.; Dunnet, S. B.; Thomas, R.; Iversen, S. D.; Bjorklund, A.; Stenevi, U. Function recovery following neural transplantation of embryonic septal nuclei in adult rats with septohippocampal lesions. Nature 300:260-262; 1982.
32. 2 muscarinic receptors in guinea pig hippocampal mossy fiber-CA3 synapses. Brain Res. 619:324-330; 1993.
33. 33. McClearn, G. E.; Wilson, J. R.; Meredith, W. The use of isogenic and heterogenic mouse stocks in behavioral research. In: Lindzey, G.; Thiessen, D. D., eds. Contribution to behavioral-genetic analysis: The mouse as a prototype. New York: Appleton-Century-Crofts; 1970:3-22.
34. 2 muscarinic receptors that are separately coupled to two biochemical effector systems. Mol. Pharmacol. 35(1):39-47; 1989.
35. 35. Morris, R. Development of water maze procedure for studying spatial learning in the rat. J. Neurosci. Methods 11:47-60; 1984.
36. 36. Morris, R. M. G.; Anderson, E.; Lynch, G. S.; Baudry, M. Selective impairment of learning and blockade of long-term potentiation by an N-methyl-aspartate receptors agonist, AP5. Nature 319:774-776; 1986.
37. 37. Murrin, L. C. High-affinity transport of choline in neuronal tissue. Pharmacology 21:132-140; 1980.
38. 38. Nathnson, N. M. Regulation and development of muscarinic receptor number and function. Muscarin. Recept. 419-454; 1989.
39. 39. Nilsson, O. G.; Shapiro, M. L.; Gage, F. H.; Olton, D. S.; Bjorklund, A. Spatial learning and memory following fimbria-fornix lesion and grafting of fetal septal neurons to the hippocampus. Exp. Brain Res. 67:195-215; 1987.
40. 40. Nishizuka, Y. Three multifunctional protein kinase systems in transmembrane control. Mol. Biol. Biochem. Biophys. Mol. Biol. Biochem. Biophys. 32:113-135; 1980.
41. 41. Nishizuka, Y. The role of protein kinase c in cell surface signal transduction and tumour promotion. Nature 308:693-697; 1984.
42. 42. Nishizuka, Y. Studies and perspectives of protein kinase C. Science 233:305-311; 1986.
43. 43. Norberg, A.; Wahlstrom, G. Effect of long-term oral barbital administration on endogenous acetylcholine in different regions of the rat brain. Eur. J. Pharmacol. 43:237-242; 1977.
44. 44. Ohkuma, S.; Kisi, M.; Fu-Hai, M. A.; Kuriyama, K. Association of functional alteration in intracellular signal transduction system with the occurrence of up-regulation of muscarinic receptors in primary cultured neurons. Prog. NeuroPsychopharmacol. Biol. Psychiatr. 16:413-424; 1992.
45. 45. Olton, D. S.; Samuelson, R. J. Remembrance of places passed: spatial memory in rats. J. Exp. Psychol. Animal Behav. Proc. 2:97-116; 1976.
46. 46. Pakzalian, P.; Isaccson, O. Neural xenotransplantation: Reconstruction of neural circuitry across species barriers. Neuroscience 62:989-1001; 1994.
47. 47. Perlow, M. J.; Freed, W. J.; Hoffer, B. J.; Seiger, A.; Olson, L; Wyatt, R. J. Brain grafts reduce motor abnormalities produced by destruction of nigrostriatal dopamine system. Science 204:643-647; 1979.
48. 48. Pick, C. G.; Yanai, J. Long-term reduction in eight arm maze performance after early exposure to phenobarbital. Int. J. Dev. Neurosci. 3(3):223-227; 1985.
49. 49. Pick, C. G.; Weizman, A.; Fares, F.; Gavish, M.; Kanner, B. I.; Yanai, J. Hippocampal γ-aminobutyric acid and benzodiazepine receptors after early phenobarbital exposure. Dev. Brain Res. 74:111-116; 1993.
50. 50. Pratt, R. M. Hormones, growth factors, and their receptors in normal and abnormal prenatal development. In: Kalter, H., eds. Issues and reviews in teratology. New York: Plenum Press; 1984:189-209.
51. 51. Reinisch, M. C.; Sanders, S. A.; Mortensen, E. L.; Psych, C.; Rubin, D. B. In utero exposure to phenobarbital and intelligence deficits in adult men. JAMA 274(19):1518-1525; 1995.
52. 52. Richards, M. H. Pharmacology and second messenger interactions of cloned muscarinic receptors. Biochem. Pharmacol. 42:1645-1653; 1991.
53. 53. Robinson, S.; Malthe-Sorenssen, D.; Wood, P.; Commissiong, J. Dopaminergic control of the septal hippocampal cholinergic pathway. J. Pharmacol. Exp. Ther. 208:476; 1979.
54. 54. Rogel-Fuchs. Y.; Newman, M. E.; Trombka, D.; Zahalka, E. A.; Yanai J. Hippocampal cholinergic alterations and related behavioral deficits after early exposure to phenobarbital. Brain Res. Bull. 29:1-6; 1992.
55. 55. Rogel-Fuchs, Y.; Zahalka, E.; Yanai, J. Reversal of early phenobarbital-induced cholinergic and related behavioral deficits by neuronal grafting. Brain Res. Bull. 33:273-279; 1994.
56. 56. Sabel, B. A.; Labbe, R.; Stein, D. G. The saline effect: Minimizing the severity of brain damage if secondery degeneration. Exp. Neurol. 881:95-107; 1985.
57. 57. Saitoh, Y.; Matsui, Y.; Nihonmatsu, I.; Kawamura, H. Crossspecies transplantation of the suprachiasmatic nuclei from rats to Siberian chipmunks (Eutamias Sibiricus) with suprachiasmatic lesions. Neurosci. Lett. 123:77-81; 1991.
58. 14C] acetylcholine from rat brain cortex slices. J. Pharmacol. Pharm. 21:546; 1969.
59. 59. Siegel, S. Non-parametric statistics for the behavioral sciences. New York: McGraw-Hill; 1956.
60. 60. Simon, J. R.; Atweh, S.; Kuhar, M. J. Sodium-dependent high affinity choline uptake: A regulatory step in the synthesis of acetylcholine. J. Neurochem. 26:909-922; 1976.
61. 61. Slotkin, T. A.; Nemeroff, C. B.; Bissette, G.; Seidler, F. J. Overexpression of the high affinity choline transporter in cortical regions affected by Alzheimer's disease: Evidence from rapid autopsy studies. J. Clin. Invest. 94:696-702; 1994.
62. 62. Snyder, E. Y. Grafting immortalized neurons to the CNS. Curr. Opin. Neurobiol. 4:742-751; 1994.
63. 63. Sokolovsky, M. Muscarinic cholinergic receptors and their inter actions with drugs. Adv. Drug Res. 18:431-509: 1989.
64. 64. Solberg, Y.; Pollack, Y.; Silverman, W. F. Expression of tyrosine hydroxylase mRNA in transplanted dopamine neurons, Neurosci. Lett. 106:36-42.; 1989.
65. 65. Springer, J. E.; Collier, T. J.; Sladek, J. R. Jr.; Loy, R. Transplantation of male mouse submaxillary gland increases survival of axotomized basal forebrain neurons. J. Neurosci. Res. 19:291-296; 1988.
66. 66. Staubli, U.; Rogers, G.; Lynch, G. Facilitation of glutamate receptors enhances memory, Proc. Natl. Acad. Sci. USA 91:777-781; 1994.
67. 67. Thompsos, G. W. Successful brain grafting. N.Y. Med. 2:701-702; 1980.
68. 3H]hemicholinium-3 in the rat brain: A potentially selective marker for presynaptic cholinergic sites. Life Sci. 35:2335-2343; 1984.
69. 3H]Pirenzepine selectively identifies a high affinity population of muscarinic cholinergic receptors in the rat cerebral cortex. Life Sci. 31:2019-2023; 1982.
70. 70. Wehner, J. M.; Sleight, S.; Upchurch, M. Hippocampal protein kinase C activity is reduced in poor spatial lerners. Brain Res. 523:181-187; 1990.
71. 3-monoacetyl-morphine. J. Organ. Chem. 19:1409-1415; 1954.
72. 72. Weiner, B. J. Statistical principles in experimental design. New York: McGraw-Hill; 1971.
73. 73. Yanai, J; Preface, In: Yanai, J., ed. Neurobehavioral teratology. Amsterdam: Elsevier; 1984:V-X.
74. 74. Yanai, J. An animal model for the effect of barbiturate on the development of the central nervous system. In: Yanai, J., ed. Neurobehavioral teratology. Amsterdam: Elsevier, Amsterdam; 1984:111-132.
75. 75. Yanai, J.; Pick, C. G. Studies on noradrenergic alternations in relation to early phenobarbital-induced behavioral changes. Int. J. Dev. Neurosci. 5:337-344; 1987.
76. 76. Yanai, J.; Pick, C. G. Neuron transplantation reverses phenobarbital-induced behavioral birth defects in mice. Int. J. Dev. Neurosci. 6:409-416; 1988.
77. 77. Yanai, J.; Sze, P. Y.; Iser, C.; Melamed, E. Studies on brain monoamine neurotransmitters in mice after prenatal exposure to barbiturate. Pharmacol. Biochem. Behav. 23:215-219; 1985.
78. 78. Yanai, J.; Greenfeld, Z.; Laxer, U.; Pick, C. G.; Trombka, D.; Weinstein, D. CNS changes after early barbiturate exposure: Mechanisms and reversal. In: Fujii, T.; Adams, P. M., eds, Functional teratogenesis. Tokyo: Tokyo University Press; 1987: 121-130.
79. 79. Yanai, J.; Laxer, U.; Pick, C. G.; Trombka, D. Dopaminergic denervation reverses behavioral deficits induced by prenatal exposure to phenobarbital. Dev. Brain Res. 48:255-261; 1989.
80. 80. Yanai, J.; Avraham, J.; Maslaton, J.; Rogel-Fuchs, Y.; Zahalka, E. A. Alterations in septohippocampal cholinergic innervations and related behaviors after early exposure to heroin and phencyclidine. Dev. Brain Res. 69:207-214; 1992.
81. 81. Yanai, J.; Abu-Roumi, M.; Avraham, Y.; Steingart, R. A. Behavioral deficits and both pre-and postsynaptic cholinergic hyperactivity after early drug-exposure. Proceedings of the DrugAbuse Conference. Madeira, Portugal. 1995: in press.
82. 82. Zagon, I. S.; McLaughlin, P. J. An overview of the neurobehavioral sequelae of prenatal opioid exposure. In: Yanai, J., ed. Neurobehavioral teratology. Amsterdam: Elsevier; 1984:197-234.
83. 3H]hemicholinium-3 binding. Neurobehav. Toxicol. Teratol. 14:375-382; 1992.